Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Nexavar Dosing in Renal Cancer Patients in "Real-life" Setting
This completed trial update describes how Nexavar (sorafenib) was dosed in renal cell carcinoma patients in real-world clinical settings.
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Phase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal Cancer [Phase 1, Phase 2]
A dose-escalation Phase I/II trial evaluating Lutetium-177-labeled cG250 for advanced/metastatic renal cell carcinoma has completed enrollme…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: CyberKnife for Unresectable Renal Tumors [NA]
A completed clinical trial evaluating CyberKnife radiosurgery for unresectable renal tumors (kidney cancer).
-
CLINICAL_TRIALS other · 2017-03-15Clinical Trial Update: Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer [Phase 1]
A Phase 1 trial combining stereotactic body radiation therapy with T-cell infusion for metastatic renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: A Study of RO4929097 in Patients With Advanced Renal Cell Carcinoma That Have Failed Vascular Endothelial Growth Factor (VEGF)/Vascular Endothelial Growth Factor Receptor (VEGFR) Therapy [Phase 2]
Phase 2 trial evaluating RO4929097 in patients with advanced renal cell carcinoma after VEGF/VEGFR therapy has completed with results posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma [Phase 2]
Phase II trial evaluating gemcitabine in combination with Doxil for metastatic renal cell carcinoma has completed, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers [Phase 1]
Phase 1 study assessing the combination of panobinostat with sorafenib in renal cell carcinoma, soft tissue sarcoma, and non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients [Phase 2]
A Phase 2 study evaluating recombinant human interleukin-21 in combination with sunitinib for stage IV renal cell carcinoma has completed.
-
CLINICAL_TRIALS research · 2017-02-17Clinical Trial Update: NCCN Renal Cell Registry [NA]
The NCCN Renal Cell Registry trial sponsored by Duke University has completed. No results are provided in the available snippet.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma [Phase 2]
A Phase 2 trial evaluating the combination of bevacizumab and temsirolimus for advanced renal cell carcinoma was terminated.
-
CLINICAL_TRIALS research · 2017-02-09Clinical Trial Update: Study of DC-CTL Combined With CIK for Advanced Solid Tumor [Phase 1, Phase 2]
Clinical trial update on a Phase 1/2 study evaluating DC-CTL therapy combined with CIK for advanced solid tumors; the current status of the …
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer [Phase 2]
Phase 2 trial of pharmacokinetically guided everolimus in patients with breast cancer, pancreatic neuroendocrine tumors, or renal cell carci…
-
CLINICAL_TRIALS research · 2017-01-24Clinical Trial Update: Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC
This clinical trial update notes completion of tumor collection from routine nephrectomy in subjects with advanced renal cell carcinoma.
-
CLINICAL_TRIALS research · 2017-01-18Clinical Trial Update: Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan)
A completed post-marketing commitment trial update for sunitinib in renal cell carcinoma with results posted in 2017.
-
CLINICAL_TRIALS research · 2017-01-18Clinical Trial Update: Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial [Phase 1, Phase 2]
A Phase I/II trial evaluating isoquercetin as an adjunct to first-line sunitinib in renal cell carcinoma (kidney cancer).
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect. [Phase 1, Phase 2]
A Phase I/II trial evaluated stereotactic body radiotherapy with concurrent fixed-dose tyrosine kinase inhibitors in metastatic renal cell c…
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors [Phase 1]
A Phase 1 clinical trial evaluating stereotactic body radiotherapy for treating primary renal cell carcinoma tumors has been terminated.
-
CLINICAL_TRIALS research · 2017-01-04Clinical Trial Update: Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer [Phase 3]
A Phase 3 trial evaluating interleukin-2 for stage III/IV kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery [Phase 3]
Phase 3 trial evaluating sunitinib malate or sorafenib tosylate for kidney cancer post-surgery has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis [Phase 4]
Phase 4 clinical trial evaluating zoledronic acid in patients with renal cell carcinoma and bone metastases has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies [Phase 2, Phase 3]
This clinical trial update reports results from a study of continued treatment with peginterferon alfa-2a or recombinant interferon alfa-2a …
-
CLINICAL_TRIALS trial_result · 2016-11-10Clinical Trial Update: Sunitinib Malate in Treating Patients With Kidney Cancer [NA]
The document reports the completion of a clinical trial evaluating sunitinib malate for kidney cancer (renal cell carcinoma). The snippet pr…
-
CLINICAL_TRIALS trial_result · 2016-11-09Clinical Trial Update: PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine [Phase 2]
Phase 2 study evaluating PD-1 inhibitor alone or with a dendritic cell/renal cell carcinoma fusion cell vaccine in renal cell carcinoma was …
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL) [Phase 1, Phase 2]
This document describes an early-phase dose-finding and safety/efficacy study of radium-223 dichloride (Xofigo) in patients with clear-cell …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) and Interferon Alpha 2a in Patients With Metastatic Renal Cell Cancer (VERA)
This clinical trial update notes the completion of an observational study evaluating Avastin (bevacizumab) in combination with interferon al…